Patents Assigned to Flex Pharma, LLC
  • Amorphous cabozantinib particles and uses thereof
    Patent number: 12564584
    Abstract: Amorphous solid dispersions of the protein kinase inhibitor cabozantinib. The amorphous solid dispersions exhibit chemical and physical stability under stressed conditions. The amorphous solid dispersions may be suitable for use in pharmaceutical compositions for administration to human subjects or patients.
    Type: Grant
    Filed: June 23, 2025
    Date of Patent: March 3, 2026
    Assignee: Flex Pharma, LLC
    Inventors: Christian F. Wertz, Tzehaw Chen, Joseph McTarsney